{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:01:19Z","timestamp":1790035279643,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                    <jats:p>\n                      Pain is the cardinal symptom of non-neurofibromatosis type 2 schwannomatosis (non-\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      -SWN), and peripheral nerve schwannomas are the most frequent tumors encountered in this condition. The role of surgery in alleviating schwannoma-associated pain in schwannomatosis remains a matter of debate in the literature.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective chart review of all non-\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      -SWN patients followed up at our Schwannomatosis Reference Center and included all patients operated from a peripheral nerve tumor.\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      -related schwannomatosis was excluded on the basis of germline genetic study and\/or absence of suggestive tumors on brain and spine MRIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Fifty-nine patients were included, suffering mostly from a nonfamilial (50\/59, 85%) and diffuse (40\/59, 68%) non-\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      -SWN. A germline genetic study of the\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">LZTR1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">SMARCB1<\/jats:italic>\n                      genes was performed in 38 patients (64%) and demonstrated a\n                      <jats:italic toggle=\"yes\">LZTR1<\/jats:italic>\n                      gene variant in 19 cases (50%). The patients were operated from 103 peripheral nerve tumors, mainly located in major nerves (n = 67, 65%) compared with subcutaneous (n = 17, 16%) and intramuscular (n = 17, 16%) cases. Most tumors were classical discrete tumors (n = 88, 85%), while multinodular cases represented only 15% (n = 15) of cases. Pathological analysis confirmed the diagnosis of schwannoma except 2 cases of hybrid neurofibroma\/schwannoma tumors. A complete resection was performed in 89% of cases with a complete relief of preoperative pain in 87% of cases. Postoperative motor and sensory deficits were encountered in 8 (8%) and 14 (14%) cases, respectively. Multinodular schwannomas were characterized by a decreased rate of complete pain relief (64% vs 90%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .007) and an increased rate of postoperative motor deficit (3% vs 35%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) compared with discrete tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>\n                      Nerve-sparing surgery using intraoperative neuro-monitoring remains effective in treating pain of non\u2013\n                      <jats:italic toggle=\"yes\">NF2<\/jats:italic>\n                      -SWN-associated peripheral nerve schwannomas, with the notable exception of multinodular tumors, also characterized by an increased rate of postoperative motor deficits.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1227\/ons.0000000000001595","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T10:00:10Z","timestamp":1745834410000},"page":"816-823","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Surgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 Schwannomatosis"],"prefix":"10.1227","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-9516","authenticated-orcid":false,"given":"Matthieu","family":"Peyre","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, APHP, Sorbonne Universit\u00e9s, Paris, France;"},{"name":"Neuro-Vascular Interfaces in Brain Tumors and Vascular Malformations, CRICM INSERM U1127 CNRS UMR 7225, Paris Brain Institute, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix","family":"Addi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Groupe Hospitalier Cochin, APHP, Universit\u00e9 Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Parfait","sequence":"additional","affiliation":[{"name":"Department of Genomic Medecine, APHP.Centre-Universit\u00e9 Paris Cit\u00e9, site Cochin, APHP, Universit\u00e9 Paris Cit\u00e9, Paris, France;"},{"name":"Genomics and Epigenetics of Rare Tumors, Institut Cochin (U1016 Inserm\/UMR8104 CNRS\/UMR-S8104), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fertitta","sequence":"additional","affiliation":[{"name":"Deparment of Dermatology (CERENEF), H\u00f4pital Henri Mondor, Assistance Publique-H\u00f4pitaux de Paris, Creteil, France;"},{"name":"INSERM Unit U955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, APHP, Sorbonne Universit\u00e9s, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[{"name":"Deparment of Dermatology (CERENEF), H\u00f4pital Henri Mondor, Assistance Publique-H\u00f4pitaux de Paris, Creteil, France;"},{"name":"INSERM Unit U955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, APHP, Sorbonne Universit\u00e9s, Paris, France;"},{"name":"Neuro-Vascular Interfaces in Brain Tumors and Vascular Malformations, CRICM INSERM U1127 CNRS UMR 7225, Paris Brain Institute, H\u00f4pital de la Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"4","key":"R1-20251114","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.46.4.1072","article-title":"Schwannomatosis: a clinical and pathologic study","volume":"46","author":"MacCollin","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"R2-20251114","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000245948","article-title":"Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2","volume":"195","author":"Wolkenstein","year":"1997","journal-title":"Dermatology"},{"issue":"9","key":"R3-20251114","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmg-2024-110065","article-title":"NF2-related schwannomatosis and other schwannomatosis: an updated genetic and epidemiological study","volume":"61","author":"Forde","year":"2024","journal-title":"J Med Genet."},{"issue":"9","key":"R4-20251114","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","article-title":"Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation","volume":"24","author":"Plotkin","year":"2022","journal-title":"Genet Med."},{"issue":"2","key":"R5-20251114","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1227\/neu.0000000000002202","article-title":"Surgical management of peripheral nerve pathology in patients with neurofibromatosis type 2","volume":"92","author":"Peyre","year":"2023","journal-title":"Neurosurgery"},{"issue":"10","key":"R6-20251114","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1634\/theoncologist.2012-0162","article-title":"Clinical features of schwannomatosis: a retrospective analysis of 87 patients","volume":"17","author":"Merker","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"R7-20251114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10143-023-02186-y","article-title":"Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas","volume":"46","author":"Peyre","year":"2023","journal-title":"Neurosurg Rev."},{"issue":"1","key":"R8-20251114","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-021-01680-0","article-title":"[18F]FDG positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET\/MRI) as a diagnosis tool in Schwannomatosis","volume":"16","author":"Gallais S\u00e9r\u00e9zal","year":"2021","journal-title":"Orphanet J Rare Dis."},{"issue":"7 Suppl 1","key":"R9-20251114","first-page":"S31","article-title":"Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis","volume":"87","author":"Ahlawat","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"R10-20251114","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neuchi.2015.01.004","article-title":"Neurofibromatosis type 2 French cohort analysis using a comprehensive NF2 molecular diagnostic strategy","volume":"64","author":"Pasmant","year":"2018","journal-title":"Neurochirurgie"},{"issue":"7","key":"R11-20251114","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noy009","article-title":"Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis","volume":"20","author":"Louvrier","year":"2018","journal-title":"Neuro Oncol."},{"issue":"1","key":"R12-20251114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ons\/opz034","article-title":"Go for the gold: a \u201cplane\u201d and simple technique for resecting benign peripheral nerve sheath tumors","volume":"18","author":"Stone","year":"2020","journal-title":"Oper Neurosurg."},{"issue":"5","key":"R13-20251114","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"issue":"2","key":"R14-20251114","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ng.2855","article-title":"Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas","volume":"46","author":"Piotrowski","year":"2014","journal-title":"Nat Genet."},{"issue":"2","key":"R15-20251114","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1212\/WNL.0000000000001129","article-title":"Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis","volume":"84","author":"Smith","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"R16-20251114","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/jmg-2024-110217","article-title":"Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for NF2-related schwannomatosis","volume":"61","author":"Smith","year":"2024","journal-title":"J Med Genet."},{"issue":"1","key":"R17-20251114","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13023-019-1176-4","article-title":"Segmental schwannomatosis: characteristics in 12 patients","volume":"14","author":"Alaidarous","year":"2019","journal-title":"Orphanet J Rare Dis."},{"issue":"2","key":"R18-20251114","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-022-04061-0","article-title":"Management of neurofibromatosis type 2 and schwannomatosis associated peripheral and intraspinal schwannomas: influence of surgery, genetics, and localization","volume":"159","author":"Gugel","year":"2022","journal-title":"J Neurooncol."},{"issue":"3","key":"R19-20251114","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3171\/2010.8.JNS091900","article-title":"Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up. Clinical article","volume":"114","author":"Gonzalvo","year":"2011","journal-title":"J Neurosurg."},{"issue":"4","key":"R20-20251114","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3171\/2017.1.JNS162292","article-title":"Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital","volume":"128","author":"Guha","year":"2018","journal-title":"J Neurosurg."},{"issue":"4","key":"R21-20251114","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.surneu.2003.11.020","article-title":"Management of patients with schwannomatosis: report of six cases and review of the literature","volume":"62","author":"Huang","year":"2004","journal-title":"Surg Neurol."},{"issue":"5","key":"R22-20251114","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.hansur.2017.07.001","article-title":"Six cases of sporadic schwannomatosis: topographic distribution and outcomes of peripheral nerve tumors","volume":"36","author":"Chick","year":"2017","journal-title":"Hand Surg Rehabil."},{"issue":"4","key":"R23-20251114","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1750-3639.2007.00086.x","article-title":"Role of NF2 haploinsufficiency in NF2-associated polyneuropathy","volume":"17","author":"Hanemann","year":"2007","journal-title":"Brain Pathol."},{"issue":"4","key":"R24-20251114","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nn.3348","article-title":"Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy","volume":"16","author":"Schulz","year":"2013","journal-title":"Nat Neurosci."},{"issue":"1","key":"R25-20251114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2045-3329-2-17","article-title":"Malignant peripheral nerve sheath tumours in inherited disease","volume":"2","author":"Evans","year":"2012","journal-title":"Clin Sarcoma Res."},{"issue":"4","key":"R26-20251114","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10689-019-00138-4","article-title":"Multiple primary malignancies associated with a germline SMARCB1 pathogenic variant","volume":"18","author":"Eelloo","year":"2019","journal-title":"Fam Cancer."},{"key":"R27-20251114","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.wneu.2018.08.087","article-title":"Malignant peripheral nerve sheath tumor arising in schwannomatosis with multiple lung metastases","volume":"119","author":"Ding","year":"2018","journal-title":"World Neurosurg."},{"issue":"5-6","key":"R28-20251114","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/cge.14121","article-title":"Neurofibromas in LZTR1 schwannomatosis","volume":"101","author":"Groen","year":"2022","journal-title":"Clin Genet."}],"container-title":["Operative Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1227\/ons.0000000000001595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:02:01Z","timestamp":1786122121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1227\/ons.0000000000001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1227\/ons.0000000000001595","relation":{},"ISSN":["2332-4252","2332-4260"],"issn-type":[{"value":"2332-4252","type":"print"},{"value":"2332-4260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"2024-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}